Literature DB >> 10600849

PKC translocation without changes in Galphaq and PLC-beta protein abundance in cardiac hypertrophy and failure.

T Jalili1, Y Takeishi, G Song, N A Ball, G Howles, R A Walsh.   

Abstract

Activation of protein kinase C (PKC) has been implicated as playing a key role in the pathogenesis of cardiac hypertrophy. This study investigates the response of several signal transduction proteins responsible for PKC activation during the transition from compensated pressure-overload hypertrophy (POH) to congestive heart failure (CHF). Pressure overload was produced on male, adult, Hartley strain guinea pigs using a ligature around the descending thoracic aorta. Sham-operated controls, POH, and CHF groups were identified based on left ventricular hypertrophy, pulmonary congestion, and isolated heart Langendorff mechanics. Quantitative immunoblotting revealed phospholipase C (PLC)-betaI and Galphaq were unchanged during POH and CHF, as were RGS2, RGS3, and RGS4 (regulators of G protein signaling, which are activators of intrinsic GTPase activity). Translocation of PKC-alpha, -epsilon, and -gamma from cytosolic to membranous fractions were significantly increased during POH and CHF. Cytosolic PKC activity was also elevated during POH. We conclude that differential PKC activation may be mediated by increases in Galphaq and PLC-betaI activity rather than upregulation of expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600849     DOI: 10.1152/ajpheart.1999.277.6.H2298

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

Review 1.  Molecular biology of protein kinase C signaling in cardiac myocytes.

Authors:  A Malhotra; B P Kang; D Opawumi; W Belizaire; L G Meggs
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

Review 2.  Designing proteins to combat disease: Cardiac troponin C as an example.

Authors:  Jonathan P Davis; Vikram Shettigar; Svetlana B Tikunova; Sean C Little; Bin Liu; Jalal K Siddiqui; Paul M L Janssen; Mark T Ziolo; Shane D Walton
Journal:  Arch Biochem Biophys       Date:  2016-02-18       Impact factor: 4.013

3.  Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  Will Soesanto; Han-Yi Lin; Eric Hu; Shane Lefler; Sheldon E Litwin; Sandra Sena; E Dale Abel; J David Symons; Thunder Jalili
Journal:  Hypertension       Date:  2009-11-02       Impact factor: 10.190

4.  Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC.

Authors:  L Chen; H Hahn; G Wu; C H Chen; T Liron; D Schechtman; G Cavallaro; L Banci; Y Guo; R Bolli; G W Dorn; D Mochly-Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 5.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

Review 6.  Protein kinase Cα as a heart failure therapeutic target.

Authors:  Qinghang Liu; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2010-10-16       Impact factor: 5.000

7.  Independent modulation of contractile performance by cardiac troponin I Ser43 and Ser45 in the dynamic sarcomere.

Authors:  Sarah E Lang; Jennifer Schwank; Tamara K Stevenson; Mark A Jensen; Margaret V Westfall
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

8.  Docosahexaenoic acid inhibits protein kinase C translocation/activation and cardiac hypertrophy in rat cardiomyocytes.

Authors:  Alicia Castillo; Nargiz Ruzmetov; Kevin A Harvey; William Stillwell; Gary P Zaloga; Rafat A Siddiqui
Journal:  J Mol Genet Med       Date:  2005-07-28

9.  Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload.

Authors:  Takahiro Nagayama; Steven Hsu; Manling Zhang; Norimichi Koitabashi; Djahida Bedja; Kathleen L Gabrielson; Eiki Takimoto; David A Kass
Journal:  J Am Coll Cardiol       Date:  2009-01-13       Impact factor: 24.094

10.  Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function.

Authors:  Debra L Rigor; Natalya Bodyak; Soochan Bae; Jun H Choi; Li Zhang; Dmitry Ter-Ovanesyan; Zhiheng He; Julie R McMullen; Tetsuo Shioi; Seigo Izumo; George L King; Peter M Kang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-02       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.